Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 144 views

    Efbu2630

    Uploaded by

    Aniruddh Naga
    The test report is for Mrs. Uma Sambu Rani Nandigam, a 52-year-old female. It shows her fasting plasma glucose was 130 mg/dL, indicating impaired fasting glucose. Her post-lunch plasma glucose was 181 mg/dL, indicating impaired glucose tolerance. Her thyroid function tests showed her T3 was 1.26 ng/mL, T4 was 15.7 μg/dL, and TSH was 0.016 μIU/mL, all within normal ranges. Her hemoglobin level was 13.0 g/dL, also within the normal range. The test results indicate prediabetes and normal thyroid and hemoglobin levels.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Efbu2630

    Uploaded by

    Aniruddh Naga
    144 views4 pages
    The test report is for Mrs. Uma Sambu Rani Nandigam, a 52-year-old female. It shows her fasting plasma glucose was 130 mg/dL, indicating impaired fasting glucose. Her post-lunch plasma glucose was 181 mg/dL, indicating impaired glucose tolerance. Her thyroid function tests showed her T3 was 1.26 ng/mL, T4 was 15.7 μg/dL, and TSH was 0.016 μIU/mL, all within normal ranges. Her hemoglobin level was 13.0 g/dL, also within the normal range. The test results indicate prediabetes and normal thyroid and hemoglobin levels.

    Original Description:

    Original Title

    59204116_EFBU2630

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The test report is for Mrs. Uma Sambu Rani Nandigam, a 52-year-old female. It shows her fasting plasma glucose was 130 mg/dL, indicating impaired fasting glucose. Her post-lunch plasma glucose was 181 mg/dL, indicating impaired glucose tolerance. Her thyroid function tests showed her T3 was 1.26 ng/mL, T4 was 15.7 μg/dL, and TSH was 0.016 μIU/mL, all within normal ranges. Her hemoglobin level was 13.0 g/dL, also within the normal range. The test results indicate prediabetes and normal thyroid and hemoglobin levels.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    144 views4 pages

    Efbu2630

    Uploaded by

    Aniruddh Naga
    The test report is for Mrs. Uma Sambu Rani Nandigam, a 52-year-old female. It shows her fasting plasma glucose was 130 mg/dL, indicating impaired fasting glucose. Her post-lunch plasma glucose was 181 mg/dL, indicating impaired glucose tolerance. Her thyroid function tests showed her T3 was 1.26 ng/mL, T4 was 15.7 μg/dL, and TSH was 0.016 μIU/mL, all within normal ranges. Her hemoglobin level was 13.0 g/dL, also within the normal range. The test results indicate prediabetes and normal thyroid and hemoglobin levels.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 4
    At a glance
    Powered by AI
    The patient underwent various blood tests including glucose, thyroid function, lipid profile, haemoglobin. The reports provide the test results and reference ranges.

    Fasting Plasma Glucose, Post Lunch Plasma Glucose, T3, T4, TSH, Lipid Profile, Haemoglobin.

    The Fasting Plasma Glucose level was 130 mg/dL, indicating diabetes according to the reference range provided.

    Vijaya Diagnostic Centre

    3-6-16 & 17, Street No. 19, Himayatnagar, Hyderabad - 500 029

    Email : info@vijayadiagnostic.com
    www.vijayadiagnostic.com

    LABORATORY TEST REPORT


    Regn Date : 11/02/2020 08:21 Sample Collection : 11/02/2020 08:26
    Name : MRS. UMA SAMBU RANI NANDIGAM Print Date : 11/02/2020 18:39
    Regn No : 59204116 Age / Sex : 52 Years / Female
    Ref By : Dr. SOUTH CENTRAL RAILWAY Regn Centre : Manikonda - 59
    Sample Type : Fluoride Plasma Ref no. :

    FASTING PLASMA GLUCOSE (FPG)


    TEST NAME RESULT BIOLOGICAL REFERENCE INTERVAL

    Fasting Plasma Glucose : 130 Normal : 70-100 mg/dL


    Impaired Fasting Glucose : 101-125 mg/dL
    Diabetes : >/=126 mg/dL
    Method : Hexokinase

    Comments / Interpretation :
    ---------------------------------
    - ADA Guidelines (2019) are adopted for the evaluation of Diabetic Status.
    POST LUNCH PLASMA GLUCOSE (PLPG)
    TEST NAME RESULT BIOLOGICAL REFERENCE INTERVAL

    2 hrs Post Lunch Plasma Glucose : 181 Normal : </= 140 mg/dL
    Impaired Glucose Tolerance : 141-199 mg/dL
    Diabetes : >/= 200 mg/dL
    Method : Hexokinase

    Comments / Interpretation :
    ---------------------------------
    - ADA Guidelines (2019) are adopted for the evaluation of Diabetic Status.

    DR.JNANKUMAR CHAUDHURI
    Certificate # MC-2657 CONSULTANT BIOCHEMIST

    Released Date 11/02/2020 15:46 Page 1 of 4


    *59204116* NABL Accredited
    Vijaya Diagnostic Centre
    3-6-16 & 17, Street No. 19, Himayatnagar, Hyderabad - 500 029

    Email : info@vijayadiagnostic.com
    www.vijayadiagnostic.com

    LABORATORY TEST REPORT


    Regn Date : 11/02/2020 08:21 Sample Collection : 11/02/2020 08:26
    Name : MRS. UMA SAMBU RANI NANDIGAM Print Date : 11/02/2020 18:39
    Regn No : 59204116 Age / Sex : 52 Years / Female
    Ref By : Dr. SOUTH CENTRAL RAILWAY Regn Centre : Manikonda - 59
    Sample Type : Serum Ref no. :

    T3,T4 & TSH


    TEST NAME RESULT BIOLOGICAL REFERENCE INTERVAL

    Total T3 : 1.26 0.60 - 1.81 ng/mL


    Method : Chemiluminescence Immuno Assay (CLIA)

    Total T4 : 15.7 Infants : 6.0 - 13.2 µg/dL


    Children : 5.5 - 12.1 µg/dL
    Adolescents : 5.5 - 11.1 µg/dL
    Adults : 4.5 - 10.9 µg/dL
    Pregnancy: 6.4 -10.7 µg/dL
    Method : Chemiluminescence Immuno Assay (CLIA)

    TSH ULTRASENSITIVE : 0.016 Infants : 0.87 - 6.15 µIU/mL


    Children : 0.67 - 4.16 µIU/mL
    Adolescents : 0.48 - 4.17 µIU/mL
    Adults : 0.55 - 4.78 µIU/mL
    Pregnancy :
    1st Trimester : 0.3 - 4.5 µIU/mL
    2nd Trimester : 0.5 - 4.6 µIU/mL
    3rd Trimester : 0.8 - 5.2 µIU/mL
    Method : Chemiluminescence Immuno Assay (CLIA)

    Comments / Interpretation :
    ---------------------------------
    - Patient preparation is particularly important for hormone studies, results of which may be markedly affected by
    many factors such as stress, position, fasting state, time of the day, preceding diet and drug therapy.
    - The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hyperthyroidism.
    - T3 is not recommended for diagnosis of hypothyroidism as decreased values have minimal clinical significance.
    - Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic
    stress and hypothyroidism.
    - Elevated level of T4 are seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum Thyroxine Binding
    Globulin.
    - Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in Thyroxine Binding
    Globulin.
    - TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos
    thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium and iodine induced or deficiency
    goiter.
    - Decreased levels of TSH may be seen in Graves Disease, Toxic multinodular Goitre, Thyroiditis, Excessive treatment
    with thyroid hormone replacement and central Hypothyroidism.

    DR.BIKASH K CHAUDHURY
    Certificate # MC-2657 CONSULTANT BIOCHEMIST

    Released Date 11/02/2020 11:25 Page 2 of 4


    *59204116* NABL Accredited
    Vijaya Diagnostic Centre
    3-6-16 & 17, Street No. 19, Himayatnagar, Hyderabad - 500 029

    Email : info@vijayadiagnostic.com
    www.vijayadiagnostic.com

    LABORATORY TEST REPORT


    Regn Date : 11/02/2020 08:21 Sample Collection : 11/02/2020 08:26
    Name : MRS. UMA SAMBU RANI NANDIGAM Print Date : 11/02/2020 18:39
    Regn No : 59204116 Age / Sex : 52 Years / Female
    Ref By : Dr. SOUTH CENTRAL RAILWAY Regn Centre : Manikonda - 59
    Sample Type : Whole Blood - EDTA Ref no. :

    HAEMOGLOBIN (Hb)
    TEST NAME RESULT BIOLOGICAL REFERENCE INTERVAL

    Haemoglobin : 13.0 12.0 - 15.0 g/dL


    Photometric measurement

    DR.SHASHIKANTH
    Certificate # MC-2657 CONSULTANT PATHOLOGIST

    Released Date 11/02/2020 11:50 Page 3 of 4


    *59204116* NABL Accredited
    Vijaya Diagnostic Centre
    3-6-16 & 17, Street No. 19, Himayatnagar, Hyderabad - 500 029

    Email : info@vijayadiagnostic.com
    www.vijayadiagnostic.com

    LABORATORY TEST REPORT


    Regn Date : 11/02/2020 08:21 Sample Collection : 11/02/2020 08:26
    Name : MRS. UMA SAMBU RANI NANDIGAM Print Date : 11/02/2020 18:39
    Regn No : 59204116 Age / Sex : 52 Years / Female
    Ref By : Dr. SOUTH CENTRAL RAILWAY Regn Centre : Manikonda - 59
    Sample Type : Serum Ref no. :

    LIPID PROFILE (LP)


    TEST NAME RESULT BIOLOGICAL REFERENCE INTERVAL

    Serum Status : Clear

    Triglycerides : 224 Normal : < 150 mg/dL


    Borderline high : 150-199 mg/dL
    High : 200-499 mg/dL
    Very high : >/= 500 mg/dL
    Method : GPO - POD

    Total Cholesterol : 176 Desirable Level : < 200 mg/dL


    Borderline : 200 – 239 mg/dL
    Undesirable : >/= 240 mg/dL
    Method : CHOD - POD

    LDL Cholesterol. : 105 Optimal : < 100 mg/dL


    Near Optimal : 100 - 129 mg/dL
    Borderline High : 130 - 159 mg/dL
    High : 160 - 189 mg/dL
    Very High : > 189 mg/dL
    Method: Calculation

    HDL Cholesterol : 26 Desirable Level : > 60 mg/dL Optimal : 40 – 60


    mg/dL Undesirable : < 40 mg/dL
    Method : Elimination-Catalase/CHOD - POD

    VLDL : 45 < 30 mg/dL


    Method: Calculation

    Total Cholesterol/HDL Cholesterol Ratio : 6.77 Low Risk : 3.3 - 4.4


    Average Risk : 4.5 - 7.1
    Moderate Risk : 7.2 - 11.0
    Method: Calculation

    LDL Cholesterol/HDL Cholesterol Ratio : 4.05 Desirable Level : 0.5 - 3.0


    Borderline Risk : 3.0 - 6.0
    High Risk : > 6.0
    Method: Calculation

    Comments / Interpretation :
    ---------------------------------
    - Lipid profile is a panel of blood tests that serves as an initial broad medical screening tool for abnormalities in lipids, the
    results of this tests can identify certain genetic diseases and can determine approximate risks for cardiovascular disease,
    certain forms of pancreatitis and other diseases.

    DR.BIKASH K CHAUDHURY
    CONSULTANT BIOCHEMIST

    Released Date 11/02/2020 11:25 Page 4 of 4


    *59204116*

    You might also like